Sfondo Header
L'angolo del dottorino
Search the site... Advanced search
✖

How pulmonary embolism is diagnosed:
D-dimer, CT pulmonary angiography and other tests

The diagnosis of pulmonary embolism is not based on a single symptom or blood test. In stable patients, the pathway begins with clinical probability: when it is sufficiently low or not high, a negative D-dimer may avoid radiological examinations; when D-dimer is positive or probability is higher, the most commonly used examination to confirm or exclude an embolism is CT pulmonary angiography.
A positive D-dimer alone does not prove the presence of pulmonary embolism. Chest X-rays, ECG, troponin and echocardiography have different roles and often help exclude other causes or assess severity, rather than replace the validated diagnostic pathway.

The approach changes in hemodynamically unstable patients, in whom the priority is to recognize a potentially fatal condition quickly and stabilize the circulation. The diagnostic pathway must therefore be adapted to the clinical situation and cannot be reconstructed independently from a laboratory result.

The main points to know are:


Before testing: clinical probability and decision rules

The symptoms of pulmonary embolism are shared with many other conditions. Shortness of breath, chest pain, tachycardia or fainting can also be caused by pneumonia, acute coronary syndrome, pneumothorax, heart failure, arrhythmias and many other disorders. To avoid both missed diagnoses and indiscriminate use of CT, the clinician first estimates the pretest probability that pulmonary embolism is actually present.
This assessment combines the medical history, physical examination and factors such as signs of deep vein thrombosis, heart rate, previous episodes of thrombosis or embolism, immobilization or recent surgery, hemoptysis and malignancy.

Tools such as the Wells score help turn these factors into probability categories that can be used in the diagnostic pathway. When clinical suspicion is very low, the PERC rule may also be applied in appropriate settings to identify people who do not need further investigations for pulmonary embolism. Other algorithms, such as YEARS, combine a small number of clinical features with D-dimer thresholds.
These rules have been validated for clinical use and are not checklists to use at home. A score calculated without a consultation, without knowing the indications and without considering alternative diagnoses can be misleading.

D-dimer: when it is useful and why an elevated level is not enough

D-dimer is a product of fibrin breakdown and tends to rise when clots form and are subsequently broken down in the body. High-sensitivity assays are primarily used for exclusion: in a patient with low or non-high clinical probability, a result below the threshold specified by the algorithm may make pulmonary embolism sufficiently unlikely to avoid imaging.
When clinical probability is high, D-dimer is generally not the appropriate basis for excluding the diagnosis: imaging is pursued according to the clinical presentation.

An elevated D-dimer does not confirm pulmonary embolism. Levels may increase with age, after surgery or trauma, during infections and inflammation, in pregnancy, malignancy and numerous other conditions. To reduce unnecessary examinations in people over 50 years of age, guidelines and prospective studies support use of an age-adjusted threshold in appropriate settings.
There are also strategies in which the threshold is adjusted to clinical probability. The meaning of the numerical value therefore depends on the assay method, the units used and the selected algorithm: comparing a personal result with a threshold found online can lead to incorrect conclusions.

CT pulmonary angiography and scintigraphy: tests that detect the embolus

CT pulmonary angiography, often referred to as CTPA, is the most widely used imaging examination in stable patients when pulmonary embolism needs to be visualized directly. Following intravenous injection of iodinated contrast medium, CT acquires images of the pulmonary arteries and can identify filling defects consistent with thrombotic material.
Besides confirming or excluding pulmonary embolism in most cases, CT can provide information on alternative diagnoses and show signs of right ventricular strain that are useful for subsequent prognostic assessment.

However, CTPA is not the best examination for everyone. In the presence of significant renal impairment or an allergy to iodinated contrast medium, or when it is desirable to limit radiation exposure in selected situations, ventilation/perfusion lung scintigraphy may be preferable; in some centers it is now also available using SPECT. The choice depends on the patient, the chest X-ray, available resources and the clinical setting.
A negative examination must always be interpreted together with clinical probability. When probability is very high and the imaging result is unconvincing, the clinician may consider additional investigations rather than automatically stopping after the first test.

ECG, chest X-ray, ultrasound, troponin and echocardiography: what they are used for

ECG and chest X-ray are often part of the initial assessment, but neither can independently confirm or exclude pulmonary embolism. The ECG may show tachycardia or signs of right heart strain, but it may also be minimally altered. The chest X-ray may be normal or show nonspecific findings and is particularly useful for looking for alternative explanations for symptoms.
Oxygen saturation and arterial blood gas analysis also help assess respiratory status, but normal values are not sufficient to exclude pulmonary embolism.

Venous ultrasonography of the lower extremities is used to look for deep vein thrombosis. If it demonstrates proximal thrombosis in a person with suspected pulmonary embolism, the finding may directly influence treatment decisions; conversely, a negative leg ultrasound does not rule out pulmonary embolism.
Echocardiography is particularly important when the patient is unstable or when the impact of pulmonary embolism on the right ventricle needs to be assessed. In stable patients, it is not normally used as the sole test to rule out an embolism. Troponin and natriuretic peptides may indicate myocardial injury or cardiac strain and contribute to risk stratification after diagnosis, but are not specific markers of pulmonary embolism.

Once acute pulmonary embolism has been documented, the pathway does not end with a simple 'positive' CT result. Blood pressure, oxygenation, right ventricular function, biomarkers and overall condition help determine how dangerous the event is and which treatment is most appropriate.

Frequently asked questions about pulmonary embolism diagnosis

Does a high D-dimer mean I have pulmonary embolism?
No. D-dimer is sensitive but poorly specific and may be elevated for many reasons. Its value depends on clinical probability and the algorithm in which it is used.

What is the main test for confirming pulmonary embolism?
In most stable patients who require imaging, the most widely used examination is CT pulmonary angiography. Ventilation/perfusion scintigraphy may be used in selected situations.

Does a normal chest X-ray rule out pulmonary embolism?
No. The chest X-ray can be normal even when an embolism is present. It is mainly used to assess other possible causes of symptoms and guide further investigations.

Can echocardiography diagnose pulmonary embolism on its own?
In a stable person, generally not. It is, however, very important for assessing the right ventricle and can become a decisive immediate examination in a hemodynamically unstable patient.

Bibliography
  1. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). European Heart Journal. 2020;41(4):543-603. doi:10.1093/eurheartj/ehz405.
  2. National Institute for Health and Care Excellence. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. NICE guideline NG158. Published 2020, updated 2023, reviewed 2026.
  3. Writing Group for the Christopher Study Investigators. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA. 2006;295(2):172-179. doi:10.1001/jama.295.2.172.
  4. Righini M, Van Es J, Den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA. 2014;311(11):1117-1124. doi:10.1001/jama.2014.2135.
  5. van der Hulle T, Cheung WY, Kooij S, et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet. 2017;390(10091):289-297. doi:10.1016/S0140-6736(17)30885-1.
  6. Kearon C, de Wit K, Parpia S, et al. Diagnosis of pulmonary embolism with D-dimer adjusted to clinical probability. New England Journal of Medicine. 2019;381(22):2125-2134. doi:10.1056/NEJMoa1909159.
  7. Freund Y, Cachanado M, Aubry A, et al. Effect of the Pulmonary Embolism Rule-Out Criteria on subsequent thromboembolic events among low-risk emergency department patients: the PROPER randomized clinical trial. JAMA. 2018;319(6):559-566. doi:10.1001/jama.2017.21904.
  8. Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients' probability of pulmonary embolism: increasing the model's utility with the SimpliRED D-dimer. Thrombosis and Haemostasis. 2000;83(3):416-420.
  9. Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. New England Journal of Medicine. 2006;354(22):2317-2327. doi:10.1056/NEJMoa052367.
  10. Bull TM, Hountras P. Pulmonary Embolism. MSD Manual Professional Edition. Reviewed 2024, updated 2026.

Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.

Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.